Cartesian Therapeutics, Inc. Cybersecurity Tracker
Cybersecurity Tracker for Cartesian Therapeutics, Inc. including cybersecurity governance, scorecard, incidents and more.
- Cybersecurity Governance (3)
- Cybersecurity Incidents (0)
- Regulatory Actions
- Litigation
- Corporate Governance
- Company
Cybersecurity Governance
Additional cybersecurity governance available.
| Filing Date | Source |
|---|---|
| 2026-03-09 | SEC 10-K |
| 2025-03-13 | SEC 10-K |
| 2024-03-07 | SEC 10-K |
Cybersecurity Incidents
No incidents found.
Regulatory Actions Coming Soon
SEC enforcement actions, FTC orders, and state regulatory proceedings coming soon.
Additional regulatory actions
Litigation Coming Soon
Cybersecurity-related lawsuits, class actions, and settlements coming soon.
Additional litigation
Corporate Governance Coming Soon
Board directors, committees, and auditor details coming soon.
Additional corporate governance
Company
Profile
Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company developing autologous mRNA cell therapies (mRNA CAR-T) to treat autoimmune diseases, supported by a proprietary technology and in-house cGMP manufacturing platform (lead candidates include Descartes-08 and Descartes-15).
| Name | Cartesian Therapeutics, Inc. |
|---|---|
| Headquarters | Massachusetts; U.S.A |
| Employees | 66 |
| Revenue | $38.91M |
| Industry | Biotechnology |
| Sector | Healthcare |
| Ticker | RNAC |
| CIK | 1453687 |
| Website | http://www.selectabio.com |
| Category | Non-accelerated Filer |
| Fiscal Year End | December 31 |
Relationships
No known relationships.